Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project

Journal of Lipid Research

Volumn 55, Issue 6, 2014, Pages 1173-1178

  Kim, Daniel Seung ^a   Crosslin, David R ^a   Auer, Paul L ^b,c   Suzuki, Stephanie M ^a   Marsillach, Judit ^a   Burt, Amber A ^a   Gordon, Adam S ^a   Meschia, James F ^d   Nalls, Mike A ^e   Worrall, Bradford B ^f,g   Longstreth Jr , W T ^h   Gottesman, Rebecca F ⁱ   Furlong, Clement E ^a   Peters, Ulrike ^b,h   Rich, Stephen S ^f   Nickerson, Deborah A ^a   Jarvik, Gail P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d MAYO CLINIC   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Genetics; Rare variation

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ADULT; AMERICAN INDIAN; ARTICLE; ASIAN; BLACK PERSON; BRAIN ISCHEMIA; CAUCASIAN; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNIC DIFFERENCE; EXOME; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOTYPE; HIGH RISK POPULATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONCARDIOEMBOLIC ISCHEMIC STROKE; PHENOTYPE; PON1 GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE VARIANT; SMOKING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; ENZYMOLOGY; GENETIC VARIATION; GENETICS; METABOLISM; MULTICENTER STUDY;

AFRICAN CONTINENTAL ANCESTRY GROUP; ARYLDIALKYLPHOSPHATASE; BRAIN ISCHEMIA; EXOME; FEMALE; GENETIC VARIATION; HUMANS; MALE; STROKE;

EID: 84901675897     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P049247     Document Type: Article

References (20)

1. Voight, B. F., G. M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M. K. Jensen, G. Hindy, H. Hólm, E. L. Ding, T. Johnson, e t al. 2012. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet. 380: 572-580.
2. AIM-HIGH Investigators, W. E. Boden, J. L. Probstfi eld, T. Anderson, B. R. Cha itman, P. Desvignes-Nickens, K. Koprowicz, R. McBride, K. Teo, and W. Weintraub. 2011. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365: 2255-2267.
3. Jarvik , G. P., L. S. Rozek, V. H. Brophy, T. S. Hatsukami, R. J. Richter, G. D. Schellenberg, and C. E. Furlong. 2000. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype. Art erioscler. Thromb. Vasc. Biol. 20: 2441-2447.
4. Jarvik, G. P., R. Jampsa, R. J. Richter, C. S. Carlson, M. J. Rieder, D. A. Nickerson, and C. E. Furlong. 2003. Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics. 13: 291-295.
5. Brophy, V. H., R. L. Jampsa, J. B. Clendenning, L. A. McKinstry, G. P. Jarvik, and C. E. Furlong. 2001. Effects of 5 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am. J. Hum. Genet. 68: 1428-1436.
6. Jarvik, G. P., T. S. Hatsukami, C. Carlson, R. J. Richter, R. Jampsa, V. H. Brophy, S. Margolin, M. Rieder, D. Nickerson, and G. D. Schellenberg. 2003. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler. Thromb. Vasc. Biol. 23: 1465-1471.
7. Kim, D. S., A. A. Burt, J. E. Ranchalis, R. J. Richter, J. K. Marshall, J. F. Eintracht, E. A. Rosenthal, C. E. Furlong, and G. P. Jarvik. 2012. Additional common polymorphisms in the PON gene cluster predict PON1 activity but not vascular disease. J. Lipids. 2012: 476316.
8. Wheeler, J. G., B. D. Keavney, H. Watkins, R. Collins, and J. Danesh. 2004. Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studies. Lancet. 363: 689-695.
9. Wang, M., X. Lang, L. Zou, S. Huang, and Z. Xu. 2011. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies. Atherosclerosis. 214: 377-385.
10. Eichler, E. E., J. Flint, G. Gibson, A. Kong, S. M. Leal, J. H. Moore, and J. H. Nadeau. 2010. Missing heritability and strategies for fi nding the underlying causes of complex disease. Nat. Rev. Genet. 11: 446-450.
11. Tennessen, J. A., A. W. Bigham, T. D. O Connor, W. Fu, E. E. Kenny, S. Gravel, S. McGee, R. Do, X. Liu, G. Jun, et al, NHLBI Exome Sequencing Project. 2012. Evolution and functional impa ct of rare coding variation from deep sequencing of human exomes. Science. 337: 64-69.
12. Cooper, G. M., E. A. Stone, G. Asimenos, NISC Comparative Sequencing Program, E. D. Green, S. Batzoglou, and A . Sidow. 2005. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 15: 901-913.
13. Zheng, X., D. Levine, J. Shen, S. M. Gogarten, C. Laurie, and B. S. Weir. 2012. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics. 28: 3326-3328.
14. Wu, M. C., S. Lee, T. Cai, Y. Li, M. Boehnke, and X. Lin. 2011. Rarevariant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89: 82-93.
15. Skol, A. D., L. J. Scott, G. R. Abecasis, and M. Boehnke. 2006. Joint analysis is more effi cient than replication-based analysis for twostage genome-wide association studies. Nat. Genet. 38: 209-213.
16. Go, A. S., D. Mozaffarian, V. L. Roger, E. J. Benjamin, J. D. Berry, M. J. Blaha, S. Dai, E. S. Ford, C. S. Fox, S. Franco, et al, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2014. Heart disease and stroke statistics2014 update: a report from the American H eart Association. Circulation. 129: e28-e292.
17. Schwamm, L. H., M. J. Reeves, W. Pan, E. E. Smith, M. R. Frankel, D. Olson, X. Zhao, E. Peterson, and G. C. Fonarow. 2010. Race/et hnicity, quality of care, and outcomes in ischemic stroke. Circulation. 121: 1492-1501.
18. Zuk, O., E. Hechter, S. R. Sunyaev, and E. S. Lander. 2012. The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA. 109: 1193-1198.
19. Kim, D. S., A. A. Burt, J. E. Ranchalis, E. R. Jarvik, E. A. Rosenthal, T. S. Hatsukami, C. E. Furlong, and G. P. Jarvik. 2013. Novel geneby-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol. J. Lipid Res. 54: 1512-1520.
20. Kim, D. S., A. A. Burt, J. E. Ranchalis, R. J. Richter, J. K. Marshall, K. S. Nakayama, E. R. Jarvik, J. F. Eintracht, E. A. Rosenthal, C. E. Furlong, et al. 2012. Dietary cholesterol increases paraoxonase 1 enzyme activity. J. Lip id Res. 53: 2450-2458.